Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group study

1997 ◽  
Vol 41 (1) ◽  
pp. 75-78 ◽  
Author(s):  
D. R. Gandara ◽  
Martin J. Edelman ◽  
John J. Crowley ◽  
Derick H. M. Lau ◽  
Robert B. Livingston
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Oncology Group ◽  
Small Cell Lung ◽  
Oncology Group Study ◽  
Southwest Oncology Group ◽  
Southwest Oncology Group Study

A Phase II trial of carboplatin and vindesine in patients with non-small cell lung cancer. A Hellenic Cooperative Oncology Group study

Lung Cancer ◽  
1993 ◽  
Vol 10 (1-2) ◽  
pp. 85-89
Author(s):  
Nicholas A. Pavlidis ◽  
George Klouvas ◽  
Costas Nicolaides ◽  
Apostolos Karantanas ◽  
Marios Beer ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Oncology Group ◽  
Small Cell Lung ◽  
Oncology Group Study

Bortezomib (PS-341) in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer: A Southwest Oncology Group Phase II Trial (S0327)

2006 ◽  
Vol 1 (9) ◽  
pp. 996-1001 ◽  
Author(s):  
Primo N. Lara ◽  
Kari Chansky ◽  
Angela M. Davies ◽  
Wilbur A. Franklin ◽  
Paul H. Gumerlock ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Oncology Group ◽  
Small Cell Lung ◽  
Southwest Oncology Group ◽  
Extensive Stage

Treatment of non-small-cell lung cancer with vinblastine and very high-dose cisplatin. A Southwest Oncology Group study

1991 ◽  
Vol 28 (3) ◽  
pp. 211-213 ◽  
Author(s):  
Steven M. Grunberg ◽  
John J. Crowley ◽  
Robert B. Livingston ◽  
Franco M. Muggia ◽  
John S. MacDonald ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Small Cell ◽  
High Dose ◽  
Oncology Group ◽  
Small Cell Lung ◽  
Oncology Group Study ◽  
Southwest Oncology Group ◽  
Southwest Oncology Group Study ◽  
Very High

scholarly journals Bortezomib (PS-341) in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer: A Southwest Oncology Group Phase II Trial (S0327)

2006 ◽  
Vol 1 (9) ◽  
pp. 996-1001 ◽  
Author(s):  
Primo N. Lara ◽  
Kari Chansky ◽  
Angela M. Davies ◽  
Wilbur A. Franklin ◽  
Paul H. Gumerlock ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Oncology Group ◽  
Small Cell Lung ◽  
Southwest Oncology Group ◽  
Extensive Stage
Sign in / Sign up

Export Citation Format

Share Document